Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      OxyContin maker Purdue Pharma gets interim shield from litigation

      OxyContin maker Purdue Pharma gets interim shield from litigation

      Medical Dialogues Bureau7 Nov 2019 9:00 AM IST
      U.S. Bankruptcy Judge Robert Drain said on Wednesday he would approve an order extending a stay on more than 2,600 lawsuits that accuse Purdue Pharma...
      Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection

      Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection

      Medical Dialogues Bureau6 Nov 2019 1:30 PM IST
      New Delhi: Cadila Healthcare on Tuesday said group firm Zydus Cadila has received final approval from the US health regulator for its generic version...
      Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

      Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

      Medical Dialogues Bureau6 Nov 2019 1:26 PM IST
      Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
      All formulations of Proton Pump Inhibitors have to carry warning for associated Acute Kidney Injury- CDSCO Direction

      All formulations of Proton Pump Inhibitors have to carry warning for associated Acute Kidney Injury- CDSCO Direction

      Medical Dialogues Bureau6 Nov 2019 12:30 PM IST
      New Delhi: All formulations of Proton Pump Inhibitors marketed in the country including Pantoprazole, Omeprazole, lansoprazole, Esomeprazole,...
      Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

      Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

      Medical Dialogues Bureau6 Nov 2019 10:32 AM IST
      ZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
      Japans Takeda to sell portfolio of select drugs for USD 660 million

      Japan's Takeda to sell portfolio of select drugs for USD 660 million

      Medical Dialogues Bureau6 Nov 2019 9:19 AM IST
      Takeda Pharmaceutical Co Ltd, Japan's largest drugmaker, said on Tuesday it would sell some of its over-the-counter and prescription drugs to...
      Biocon gets EIR from USFDA for Bengaluru biologics unit

      Biocon gets EIR from USFDA for Bengaluru biologics unit

      Medical Dialogues Bureau6 Nov 2019 9:19 AM IST
      New Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
      Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

      Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

      Medical Dialogues Bureau5 Nov 2019 1:05 PM IST
      The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
      Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

      Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

      Medical Dialogues Bureau5 Nov 2019 12:57 PM IST
      New Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
      Medical device maker Stryker to buy Wright Medical for USD 4 Billion

      Medical device maker Stryker to buy Wright Medical for USD 4 Billion

      Medical Dialogues Bureau5 Nov 2019 12:56 PM IST
      Medical device maker Stryker Corp said on Monday it would buy smaller rival Wright Medical Group for about $4 billion in cash.The deal for $30.75 per...
      Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

      Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

      Medical Dialogues Bureau5 Nov 2019 12:55 PM IST
      New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
      Alleged carcinogenic impurity in Ranitidine: Dr Reddys Laboratories makes Rs 40-crore provisioning in PnL for market impact

      Alleged carcinogenic impurity in Ranitidine: Dr Reddy's Laboratories makes Rs 40-crore provisioning in PnL for market impact

      Medical Dialogues Bureau5 Nov 2019 12:52 PM IST
      Hyderabad: Dr Reddy's Laboratories, which initiated a voluntary recall of its Ranitidine from the US market following the ongoing investigation by the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok